Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of diseases. The company’s RNA therapeutics platform enables development of all types of RNA medicines including small interfering RNA (siRNA), messenger RNA (mRNA), antisense RNA, microRNA and gene editing therapeutics. Arcturus Therapeutics collaborates with industry leaders including Janssen Pharmaceuticals and Ultragenyx Pharmaceutical. It is founded in 2013 and is headquartered in San Diego, California.